C57BL/6N-Npc1tm1a(EUCOMM)Hmgu/H
Status | Available to order |
EMMA ID | EM:04739 |
Citation information | RRID:IMSR_EM:04739 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Npc1tm1a(EUCOMM)Hmgu/H |
Alternative name | HEPD0534_4_G05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Npc1tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Npc1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0534_4_G05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac males |
Breeding at archiving centre | Chimeras were mated to C57BL/6N Tac USA, and maintained on this background thereafter. |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Niemann-Pick disease type C, late infantile neurologic onset / Orphanet_216978
- Niemann-Pick disease type C, adult neurologic onset / Orphanet_216986
- Niemann-Pick disease type C, severe early infantile neurologic onset / Orphanet_216975
- Niemann-Pick disease type C, juvenile neurologic onset / Orphanet_216981
- Niemann-Pick disease type C, severe perinatal form / Orphanet_216972
IMPC phenotypes (allele matching)
MGI phenotypes (gene matching)
- impaired fertilization / MGI
- enlarged liver / MGI
- pale liver / MGI
- abnormal hepatocyte morphology / MGI
- enlarged spleen / MGI
- tremors / MGI
- decreased brain size / MGI
- decreased corpus callosum size / MGI
- abnormal cerebral cortex morphology / MGI
- abnormal olfactory bulb morphology / MGI
- abnormal pons morphology / MGI
- small cerebellum / MGI
- abnormal cerebellum anterior vermis morphology / MGI
- abnormal cerebellum posterior vermis morphology / MGI
- Purkinje cell degeneration / MGI
- abnormal Purkinje cell morphology / MGI
- decreased Purkinje cell number / MGI
- abnormal myelination / MGI
- demyelination / MGI
- abnormal CNS glial cell morphology / MGI
- abnormal trigeminal ganglion morphology / MGI
- abnormal female reproductive system morphology / MGI
- abnormal ovary morphology / MGI
- small ovary / MGI
- abnormal ovarian follicle morphology / MGI
- absent mature ovarian follicles / MGI
- absent corpus luteum / MGI
- seminiferous tubule degeneration / MGI
- arrest of spermatogenesis / MGI
- abnormal lung morphology / MGI
- thick pulmonary interalveolar septum / MGI
- decreased body weight / MGI
- weight loss / MGI
- decreased body size / MGI
- abnormal cornea morphology / MGI
- ataxia / MGI
- hypoactivity / MGI
- impaired coordination / MGI
- abnormal gait / MGI
- abnormal object recognition memory / MGI
- increased startle reflex / MGI
- abnormal lipid level / MGI
- increased circulating follicle stimulating hormone level / MGI
- increased circulating luteinizing hormone level / MGI
- nasal inflammation / MGI
- reduced fertility / MGI
- infertility / MGI
- male infertility / MGI
- female infertility / MGI
- abnormal motor capabilities/coordination/movement / MGI
- premature death / MGI
- abnormal lipid homeostasis / MGI
- abnormal respiratory system physiology / MGI
- decreased brain weight / MGI
- neurodegeneration / MGI
- abnormal type II pneumocyte morphology / MGI
- abnormal macrophage morphology / MGI
- hepatic steatosis / MGI
- oligozoospermia / MGI
- abnormal ovarian secretion / MGI
- abnormal neuron morphology / MGI
- increased liver weight / MGI
- no phenotypic analysis / MGI
- abnormal lysosome physiology / MGI
- abnormal cellular cholesterol metabolism / MGI
- astrocytosis / MGI
- nervous system phenotype / MGI
- abnormal microglial cell physiology / MGI
- abnormal cholesterol level / MGI
- increased cholesterol level / MGI
- abnormal lung vasculature morphology / MGI
- abnormal adenohypophysis morphology / MGI
- impaired acrosome reaction / MGI
- abnormal phospholipid level / MGI
- increased macrophage derived foam cell number / MGI
- abnormal surfactant composition / MGI
- decreased ovary weight / MGI
- uterus atrophy / MGI
- decreased circulating prolactin level / MGI
- decreased prolactin level / MGI
- increased circulating cholesterol level / MGI
- abnormal olfactory nerve morphology / MGI
- abnormal cholesterol homeostasis / MGI
- abnormal enzyme/coenzyme level / MGI
- increased macrophage cell number / MGI
- abnormal olfactory system morphology / MGI
- corneal deposits / MGI
- teratozoospermia / MGI
- increased lung weight / MGI
- abnormal olfactory sensory neuron morphology / MGI
- abnormal alveolar macrophage morphology / MGI
- thin myometrium / MGI
- thin endometrium / MGI
- abnormal hippocampus CA3 region morphology / MGI
- decreased lactotroph cell number / MGI
- adenohypophysis hypoplasia / MGI
- impaired olfaction / MGI
- absent sperm flagellum / MGI
- abnormal neocortex morphology / MGI
- lipidosis / MGI
- abnormal Purkinje cell dendrite morphology / MGI
- abnormal olfactory epithelium morphology / MGI
- abnormal granulosa cell morphology / MGI
- anovulation / MGI
- abnormal astrocyte physiology / MGI
- microgliosis / MGI
- absent estrous cycle / MGI
- thin uterus / MGI
- decreased endometrial gland number / MGI
- decreased prepulse inhibition / MGI
- abnormal sperm head morphology / MGI
- absent sperm head / MGI
- decreased abdominal fat pad weight / MGI
- endometrium atrophy / MGI
- abnormal secondary ovarian follicle morphology / MGI
- abnormal plasma membrane sphingolipid content / MGI
- increased plasma membrane sphingolipid content / MGI
- sphingomyelinosis / MGI
- abnormal sphingomyelin level / MGI
- foam cell reticulosis / MGI
- decreased liver cholesterol level / MGI
- increased liver cholesterol level / MGI
- axonal spheroids / MGI
- decreased grip strength / MGI
- decreased brain cholesterol level / MGI
- increased brain cholesterol level / MGI
- abnormal microglial cell activation / MGI
- abnormal alveolar lamellar body morphology / MGI
- enlarged alveolar lamellar bodies / MGI
- lethality, incomplete penetrance / MGI
- pulmonary alveolar proteinosis / MGI
- decreased food intake / MGI
- abnormal sphingolipid level / MGI
- abnormal ganglioside level / MGI
- abnormal ceramide level / MGI
- abnormal primary cilium morphology / MGI
- increased microglial cell activation / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).